BOLD · Boundless Bio, Inc.
$2.46
-0.01 (-0.40%)
At close · Jul 29
Market Cap
$55.49M
Shares
22.46M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$58.2M
+11%
FY2025
Diluted EPS
-$2.60
+32.5%
FY2025
Operating Cash Flow
-$46.66M
+23.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $42.44M | $44.85M | $55.27M | $42.64M | |
| $18.25M | $18.71M | $18M | $12.16M | |
| $1.22M | $1.25M | $1.09M | $957K | |
| $60.69M | $63.55M | $73.27M | $54.8M | |
| -$60.69M | -$63.55M | -$73.27M | -$54.8M | |
| $4.69M | $5.36M | $7.89M | $5.28M | |
| $4.69M | $5.36M | $7.9M | $5.36M | |
| — | $0 | $0 | — | |
| -$55.99M | -$58.2M | -$65.36M | -$49.43M | |
| -$56.05M | -$58.25M | -$65.28M | -$49M | |
| USD/shares | — | -$2.60 | -$3.85 | -$40.65 |
| USD/shares | — | -$2.60 | -$3.85 | -$40.65 |
| shares | — | 22.36M | 16.98M | 1.22M |
| shares | — | 22.36M | 16.98M | 1.22M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.85×
EV/EBIT
—
Peer median 41.41×
P/E (TTM)
—
Peer median 1.60×
Peer medians compare against the 292 similar-size Biotechnology companies (of 522 listed).